arrow
J

Julia Beck

university of basel
H指数:25
被引数:2,666

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hyponatremia correction is associated with increased brain-derived neurotrophic factor levels: A pilot secondary analysis of a randomized, double-blind, placebo-controlled, crossover trial

低钠血症纠正与脑源性神经营养因子水平升高相关:一项随机、双盲、安慰剂对照、交叉试验的初步二次分析

2026-09-060
OAAI
A Randomized Trial of Targeted Hyponatremia Correction in Hospitalized Patients

住院患者靶向性低钠血症纠正的随机试验

2026-02-241
PRE
Volume status of patients with hyponatremia across the age span – results from a large prospective international study

不同年龄段低钠血症患者的容量状态——一项大型前瞻性国际研究的结果

2026-01-010
OA
EndoCompass Project: Research Roadmap for Diabetes, Obesity, and Metabolism

EndoCompass 项目:糖尿病、肥胖和代谢研究路线图

2025-12-010
PRE
EndoCompass project: research roadmap for diabetes, obesity, and metabolism

EndoCompass项目:糖尿病、肥胖和代谢研究的路线图

2025-10-010
PRE
Sustained allogeneic kidney graft operational tolerance despite discontinued conventional immunosuppression after CD19-CAR-T-cell therapy for relapsed/refractory post-transplantation lymphoproliferative disorder

尽管在CD19-CAR-T细胞疗法用于治疗复发/难治性移植后淋巴增生性疾患后停用了常规免疫抑制治疗,但仍维持了同种异体肾移植物的运作性耐受。

2025-09-170
OAAI
Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT)

Nivolumab作为化疗放疗的辅助治疗在局部肌肉浸润性尿路上皮癌中的应用:一项多中心、单臂、II期、研究者发起试验(NEXT)的初步分析

2025-03-182
OA
Final results of IMPACT 2, a randomized study evaluating molecular profiling and targeted agents in metastatic cancer at MD Anderson Cancer Center

IMPACT 2研究的最终结果,这是一项在MD Anderson癌症中心进行的随机研究,旨在评估转移性癌症中的分子分型和靶向药物。

2024-09-010
PRE
Psychopathological characteristics in patients with arginine vasopressin deficiency (central diabetes insipidus) and primary polydipsia compared to healthy controls

与健康对照组相比,精氨酸加压素缺乏症 (中枢性尿崩症) 和原发性烦渴患者的心理病理学特征

2024-03-292
OA
Liquid biopsy signature combining copy number instability and mutant KRAS detection is associated with survival for patients with metastatic pancreatic cancer
2023-04-040
PRE
Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination-specific humoral and cellular immunity in kidney transplant recipients
2022-05-0966
OAAI